High incidence of carbapenemase-producing
Journal
JAC-antimicrobial resistance
ISSN: 2632-1823
Titre abrégé: JAC Antimicrob Resist
Pays: England
ID NLM: 101765283
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
03
10
2022
accepted:
14
03
2023
medline:
14
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
Carbapenem-resistant Strains isolated from wounds ( Forty-three percent of the isolates were resistant to all antibiotic categories tested. More than 40% of the isolates were resistant to the carbapenems imipenem and/or meropenem (39% and 44%, respectively). Among the meropenem-resistant isolates, 48 (89%) carried at least one carbapenemase gene. The predominant one was The study revealed a high rate of carbapenem resistance and conjugative, broad host range plasmids carrying carbapenemase-encoding genes, especially the NDM-1 type, among isolates of
Sections du résumé
Background
UNASSIGNED
Carbapenem-resistant
Methods
UNASSIGNED
Strains isolated from wounds (
Results
UNASSIGNED
Forty-three percent of the isolates were resistant to all antibiotic categories tested. More than 40% of the isolates were resistant to the carbapenems imipenem and/or meropenem (39% and 44%, respectively). Among the meropenem-resistant isolates, 48 (89%) carried at least one carbapenemase gene. The predominant one was
Conclusions
UNASSIGNED
The study revealed a high rate of carbapenem resistance and conjugative, broad host range plasmids carrying carbapenemase-encoding genes, especially the NDM-1 type, among isolates of
Identifiants
pubmed: 37051191
doi: 10.1093/jacamr/dlad038
pii: dlad038
pmc: PMC10084947
doi:
Types de publication
Journal Article
Langues
eng
Pagination
dlad038Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.
Références
J Med Microbiol. 2019 Mar;68(3):336-338
pubmed: 30667355
PLoS One. 2010 Jun 25;5(6):e11147
pubmed: 20593022
Environ Sci Pollut Res Int. 2018 Nov;25(33):33538-33547
pubmed: 30267350
PLoS One. 2014 Sep 04;9(9):e107008
pubmed: 25187957
Rev Argent Microbiol. 2020 Oct - Dec;52(4):298-304
pubmed: 31983491
FEMS Microbiol Rev. 2011 Sep;35(5):736-55
pubmed: 21303394
Pediatr Pulmonol. 2018 Sep;53(9):1269-1275
pubmed: 29968973
Antimicrob Agents Chemother. 1999 Feb;43(2):400-2
pubmed: 9925544
J Glob Antimicrob Resist. 2020 Jun;21:130-131
pubmed: 32243918
J Enzyme Inhib Med Chem. 2017 Dec;32(1):917-919
pubmed: 28719998
J Glob Antimicrob Resist. 2020 Jun;21:211-217
pubmed: 31654790
Microb Drug Resist. 2016 Jul;22(5):412-31
pubmed: 26866778
Int J Antimicrob Agents. 2017 Nov;50(5):629-639
pubmed: 28705671
JAC Antimicrob Resist. 2022 Jun 17;4(3):dlac060
pubmed: 35733913
J Antimicrob Chemother. 2020 Apr 1;75(4):911-916
pubmed: 31960033
J Glob Antimicrob Resist. 2020 Jun;21:8-12
pubmed: 31525542
Antimicrob Agents Chemother. 2021 Mar 18;65(4):
pubmed: 33526490
Infect Disord Drug Targets. 2021;21(6):e170721187999
pubmed: 33200719
Crit Rev Microbiol. 2016;42(2):276-92
pubmed: 25159043
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28630206
Biotechnol Adv. 2019 Jan - Feb;37(1):177-192
pubmed: 30500353
Int J Antimicrob Agents. 2014 May;43(5):412-7
pubmed: 24613608
Curr Microbiol. 2021 Dec 14;79(1):27
pubmed: 34905085
J Clin Microbiol. 2017 Aug;55(8):2321-2333
pubmed: 28381609
PLoS One. 2015 Mar 23;10(3):e0123690
pubmed: 25798828
Nat Commun. 2020 Mar 13;11(1):1370
pubmed: 32170080
Ann Clin Microbiol Antimicrob. 2015 Sep 02;14:39
pubmed: 26328550
J Antimicrob Chemother. 2015 Jan;70(1):103-10
pubmed: 25182064
Infect Drug Resist. 2020 Jan 30;13:285-293
pubmed: 32099420
J Antimicrob Chemother. 2020 Dec 1;75(12):3491-3500
pubmed: 32780112
BMC Genomics. 2014 Aug 29;15:737
pubmed: 25168460
Nucleic Acids Res. 2016 Jul 8;44(W1):W16-21
pubmed: 27141966
Niger J Clin Pract. 2018 Feb;21(2):176-182
pubmed: 29465051
Mol Biol Evol. 2018 Feb 1;35(2):518-522
pubmed: 29077904
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
J Ophthalmic Inflamm Infect. 2011 Sep;1(3):95-103
pubmed: 21484175
J Antimicrob Chemother. 2019 May 1;74(5):1244-1252
pubmed: 30753505
West Afr J Med. 2021 Nov 30;Vol. 38(11):1072-1079
pubmed: 34921543
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30782988
Bioinformatics. 2016 Mar 15;32(6):929-31
pubmed: 26576653
APMIS. 2013 Feb;121(2):146-52
pubmed: 23030521
J Lab Physicians. 2019 Oct-Dec;11(4):287-291
pubmed: 31929692
Euro Surveill. 2012 Nov 08;17(45):
pubmed: 23153474
Burns. 2013 Feb;39(1):168-73
pubmed: 22386976
J Comput Biol. 2013 Oct;20(10):714-37
pubmed: 24093227
J Glob Antimicrob Resist. 2020 Jun;21:42-45
pubmed: 31472281
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634
Ann Lab Med. 2023 Mar 1;43(2):196-199
pubmed: 36281514
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Nat Methods. 2017 Jun;14(6):587-589
pubmed: 28481363
mSphere. 2020 Aug 19;5(4):
pubmed: 32817379
Niger Postgrad Med J. 2009 Sep;16(3):186-92
pubmed: 19767904
Diagn Microbiol Infect Dis. 2021 Sep;101(1):115422
pubmed: 34111650
Microb Drug Resist. 2021 Aug;27(8):1063-1070
pubmed: 33332204
J Infect Dev Ctries. 2019 Apr 30;13(4):284-290
pubmed: 32045372
Wellcome Open Res. 2018 Sep 24;3:124
pubmed: 30345391
Nig Q J Hosp Med. 2013 Oct-Dec;23(4):269-72
pubmed: 27276754
Antimicrob Agents Chemother. 2009 Dec;53(12):5046-54
pubmed: 19770275
J Antimicrob Chemother. 2014 Jul;69(7):1804-14
pubmed: 24603963
Infect Disord Drug Targets. 2021;21(1):90-98
pubmed: 31957616
Clin Microbiol Rev. 2009 Oct;22(4):582-610
pubmed: 19822890
Front Microbiol. 2021 Feb 18;12:614058
pubmed: 33679638
J Med Microbiol. 2013 Apr;62(Pt 4):499-513
pubmed: 23329317
Bioinformatics. 2015 Feb 15;31(4):587-9
pubmed: 25338718
J Antimicrob Chemother. 2020 Apr 1;75(4):873-882
pubmed: 31960024